INTESTINAL BURYING OF THE JEJUNAL-TUBE OF A PEG-J LEVODOPA-CARBIDOPA RELEASE SYSTEM FOR PARKINSON�S DISEASE. SUCCESSFUL ENDOSCOPIC MANAGEMENT. | Zendy

Óscar Moralejo Lozano | Zendy; Adrián Joaquín Barrajón Masa | Zendy; Michel Colmenares Bulgheroni | Zendy

Open Access

INTESTINAL BURYING OF THE JEJUNAL-TUBE OF A PEG-J LEVODOPA-CARBIDOPA RELEASE SYSTEM FOR PARKINSON�S DISEASE. SUCCESSFUL ENDOSCOPIC MANAGEMENT.

Author(s) -

Óscar Moralejo Lozano,

Adrián Joaquín Barrajón Masa,

Michel Colmenares Bulgheroni

Publication year - 2020

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2020.7180/2020

Subject(s) - medicine , carbidopa , parkinson's disease , levodopa , peg ratio , immediate release , gastroenterology , feeding tube , disease , pharmacology , surgery , finance , economics

Levodopa-carbidopa intestinal gel (LCIG) continuous infusion into the jejunum through a percutaneous endoscopic gastrostomy with a jejunal extension (PEG-J) is an alternative therapy for Parkinson's disease (PD) patients, with a very poor control of their symptoms on regular oral medications (Hoehn-Yahr stage IV). Around 62.2 % of patients present procedure and device-related adverse effects (AE), with an 8.2 % rate of mayor complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research